|Master of Science (M.Sc.), Biochemistry|
|Bachelor of Science (B.Sc.), Biochemistry and Molecular Biology|
|Tokyo University of Foreign Studies||1984|
|Nihongo Gakko, Japanese, Japanese Language for Monbusho Scholarship Holders|
|University of Washington||1996|
|Ph.D., Molecular Biology, Cell Biology, Genetics|
Pek Lum leads Ayasdi’s products and solutions team. After more than a decade in the life sciences industry, Pek has the passion to help find a cure to cancer and other diseases in her lifetime, and believes that Ayasdi’s technology may help solve these difficult problems. Pek was trained in molecular genetics and cell biology for her Ph.D. at the University of Washington. Her work has been widely published in scientific and medical journals, and her research has contributed to discoveries in drug development and the understanding of complex diseases. Pek spent 10 years at Rosetta Inpharmatics and was part of Merck’s $620M acquisition of Rosetta in 2001, one of the companies that in many circles is known to have started the genetics revolution with its bioinformatics solution for deciphering enormous amounts of gene-expression data to derive insights into numerous potential therapeutic targets for drug discovery. Pek also has a Master of Science in Biochemistry from Hokkaido University in Japan, speaks more than 5 languages, and lives in Palo Alto with her husband and two children.